Literature DB >> 2412893

Direct measurements of increased free cytoplasmic Ca2+ in mouse pancreatic beta-cells following stimulation by hypoglycemic sulfonylureas.

H Abrahamsson, P O Berggren, P Rorsman.   

Abstract

The effects of the hypoglycemic sulfonylureas tolbutamide and glibenclamide on free cytoplasmic Ca2+, [Ca2+]i, were compared with that of a depolarizing concentration of K+ in dispersed and cultured pancreatic beta-cells from ob/ob mice. [Ca2+]i was measured with the fluorescent Ca2+-indicator quin2. The basal level corresponded to 150 nM and increased to 600 nM after exposure to 30.9 mM K+. The corresponding levels after stimulation with 1 microM glibenclamide and 100 microM tolbutamide were 390 and 270 nM respectively. K+ depolarization increased [Ca2+]i more rapidly than either of the sulfonylureas. It is suggested that the increased [Ca2+]i obtained after stimulation by sulfonylureas is due to depolarization of the beta-cells with subsequent entry of Ca2+ through voltage-dependent channels.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412893     DOI: 10.1016/0014-5793(85)80418-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Failure of glucose to elicit a normal secretory response in fetal pancreatic beta cells results from glucose insensitivity of the ATP-regulated K+ channels.

Authors:  P Rorsman; P Arkhammar; K Bokvist; C Hellerström; T Nilsson; M Welsh; N Welsh; P O Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

2.  Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells.

Authors:  B J Zünkler; S Lenzen; K Männer; U Panten; G Trube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

3.  Effects of verapamil and nifedipine on gliclazide-induced increase in cytosolic free Ca2+ in pancreatic islet cells.

Authors:  P Gobbe; A Herchuelz
Journal:  J Endocrinol Invest       Date:  1989 Jul-Aug       Impact factor: 4.256

4.  Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic beta-cells.

Authors:  M G Garrino; J C Henquin
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

5.  Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat.

Authors:  R E Buckingham; T C Hamilton; D R Howlett; S Mootoo; C Wilson
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

6.  Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells.

Authors:  G Trube; P Rorsman; T Ohno-Shosaku
Journal:  Pflugers Arch       Date:  1986-11       Impact factor: 3.657

Review 7.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

Review 8.  Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.

Authors:  Philippe E R Lheureux; Soheil Zahir; Andrea Penaloza; Mireille Gris
Journal:  Crit Care       Date:  2005-09-07       Impact factor: 9.097

9.  Measurements of membrane potential, transmembrane 45Ca fluxes, cytoplasmic free Ca2+ concentration and insulin release by transplantable rat insulinoma cells maintained in tissue culture.

Authors:  P R Flatt; H Abrahamsson; P Arkhammar; P O Berggren; P Rorsman; S K Swanston-Flatt
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.